97 related articles for article (PubMed ID: 1771885)
1. Fulminant hepatic failure following low-dose sustained-release niacin therapy in hospital.
Fischer DJ; Knight LL; Vestal RE
West J Med; 1991 Oct; 155(4):410-2. PubMed ID: 1771885
[No Abstract] [Full Text] [Related]
2. Fulminant hepatic failure after ingestion of sustained-release nicotinic acid.
Mullin GE; Greenson JK; Mitchell MC
Ann Intern Med; 1989 Aug; 111(3):253-5. PubMed ID: 2665592
[No Abstract] [Full Text] [Related]
3. Acute hepatic failure associated with the use of low-dose sustained-release niacin.
Hodis HN
JAMA; 1990 Jul; 264(2):181. PubMed ID: 2355439
[No Abstract] [Full Text] [Related]
4. Fulminant hepatic failure caused by ecarazine hydrochloride (a hydralazine derivative).
Tameda Y; Hamada M; Takase K; Nakano T; Kosaka Y
Hepatology; 1996 Mar; 23(3):465-70. PubMed ID: 8617425
[TBL] [Abstract][Full Text] [Related]
5. Adverse effects of sustained-release niacin.
Knapp TR; Middleton RK
DICP; 1991 Mar; 25(3):253-4. PubMed ID: 2028632
[No Abstract] [Full Text] [Related]
6. Safety and compliance with once-daily niacin extended-release/lovastatin as initial therapy in the Impact of Medical Subspecialty on Patient Compliance to Treatment (IMPACT) study.
Rubenfire M;
Am J Cardiol; 2004 Aug; 94(3):306-11. PubMed ID: 15276093
[TBL] [Abstract][Full Text] [Related]
7. Transient focal hepatic defects related to sustained-release niacin.
Lawrence SP
J Clin Gastroenterol; 1993 Apr; 16(3):234-6. PubMed ID: 8505497
[TBL] [Abstract][Full Text] [Related]
8. Fulminant hepatic failure associated with clarithromycin.
Shaheen N; Grimm IS
Am J Gastroenterol; 1996 Feb; 91(2):394-5. PubMed ID: 8607519
[No Abstract] [Full Text] [Related]
9. Rechallenge with crystalline niacin after drug-induced hepatitis from sustained-release niacin.
Henkin Y; Johnson KC; Segrest JP
JAMA; 1990 Jul; 264(2):241-3. PubMed ID: 2355446
[TBL] [Abstract][Full Text] [Related]
10. Niacin--the long and the short of it.
Malloy MJ; Frost PH; Kane JP
West J Med; 1991 Oct; 155(4):424-6. PubMed ID: 1771892
[No Abstract] [Full Text] [Related]
11. Nicotinic acid-induced fulminant hepatic failure.
Clementz GL; Holmes AW
J Clin Gastroenterol; 1987 Oct; 9(5):582-4. PubMed ID: 3680913
[TBL] [Abstract][Full Text] [Related]
12. [Hemorrhagic shock and fulminant hepatic failure associated with valproate].
Fernandez-Fernandez FJ; Garcia-Rego J; Garcia-Jimenez A; Sesma P
An Med Interna; 1995 Dec; 12(12):606-8. PubMed ID: 8679806
[TBL] [Abstract][Full Text] [Related]
13. Hepatic failure associated with imipramine therapy.
Shaefer MS; Edmunds AL; Markin RS; Wood RP; Pillen TJ; Shaw BW
Pharmacotherapy; 1990; 10(1):66-9. PubMed ID: 2315196
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
Harikrishnan S; Rajeev E; Tharakan JA; Titus T; Ajit Kumar VK; Sivasankaran S; Krishnamoorthy KM; Nair K
Indian Heart J; 2008; 60(3):215-22. PubMed ID: 19240310
[TBL] [Abstract][Full Text] [Related]
15. Fatal fulminant hepatic failure due to sodium valproate in an adolescent.
Puri AS; Sharma BC; Khan EM; Saraswat VA
Indian Pediatr; 1994 Feb; 31(2):207-10. PubMed ID: 7875849
[No Abstract] [Full Text] [Related]
16. Nutrition. Pilot study suggests high-dose niacin is safe and effective for some PHAs.
TreatmentUpdate; 2004 Oct; 16(6):6-7. PubMed ID: 17219680
[No Abstract] [Full Text] [Related]
17. Levofloxacin-induced acute fulminant hepatic failure in a patient with chronic hepatitis B infection.
Coban S; Ceydilek B; Ekiz F; Erden E; Soykan I
Ann Pharmacother; 2005 Oct; 39(10):1737-40. PubMed ID: 16105873
[TBL] [Abstract][Full Text] [Related]
18. Alterations in thyroid and hepatic function tests associated with preparations of sustained-release niacin.
Drinka PJ
Mayo Clin Proc; 1992 Dec; 67(12):1206. PubMed ID: 1469935
[No Abstract] [Full Text] [Related]
19. Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia.
Maccubbin D; Bays HE; Olsson AG; Elinoff V; Elis A; Mitchel Y; Sirah W; Betteridge A; Reyes R; Yu Q; Kuznetsova O; Sisk CM; Pasternak RC; Paolini JF
Int J Clin Pract; 2008 Dec; 62(12):1959-70. PubMed ID: 19166443
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis caused by low-dose sustained-release niacin.
Schwenk TL; Fisher M
J Am Board Fam Pract; 1994; 7(3):242-4. PubMed ID: 8059629
[No Abstract] [Full Text] [Related]
[Next] [New Search]
